Interinstitutional variability and effect of tissue fixative on the interpretation of a Barrett cytokeratin 7/20 immunoreactivity pattern in Barrett esophagus

Human Pathology

Volumn 36, Issue 1, 2005, Pages 58-65

  Glickman, Jonathan N ^a   Ormsby, Adrian H ^b   Gramlich, Terry L ^c   Goldblum, John R ^c   Odze, Robert D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Barrett esophagus; Cytokeratins; Immunohistochemistry

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7;

ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DEMOGRAPHY; ESOPHAGUS BIOPSY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE METAPLASIA; INTESTINE MUCOSA; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; PATHOGENESIS; PATIENT SELECTION; PROTEIN DETERMINATION; STATISTICAL SIGNIFICANCE; STOMACH ANTRUM; STOMACH MUCOSA; TECHNIQUE; TISSUE FIXATION;

EID: 13444293238     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2004.10.007     Document Type: Article

References (18)

1. G.W. Falk Barrett's esophagus Gastroenterology 122 2002 1569 1591
2. W.K. Hirota, T.M. Loughney, and D.J. Lazas Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data Gastroenterology 116 1999 277 285
3. P. Sharma, A.P. Weston, and T. Morales Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia Gut 46 2000 9 13
4. A. Couvelard, J.M. Cauvin, and D. Goldfain Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology Gut 49 2001 761 766
5. J.N. Glickman, H. Wang, and K.M. Das Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI Am. J. Surg. Pathol. 25 2001 87 94
6. A.H. Ormsby, J.R. Goldblum, and T.W. Rice Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach Hum. Pathol. 30 1999 288 294
7. A.H. Ormsby, M.F. Vaezi, and J.E. Richter Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus Gastroenterology 119 2000 683 690
8. D.G. Altman Practical statistics for medical research 1991 Chapman and Hall New York
9. J.A. Cohen A coefficient of agreement for nominal scales Educ. Psychol. Assess. 20 1960 37 46
10. H.M.T. El-Zimaity, and D.Y. Graham Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens Am. J. Gastroenterol. 96 2001 1378 1382
11. A.H. Ormsby, R.R. Tubbs, and E.D. Hsu Cytokeratin 7/20 subset expression in Barrett's esophagus: performance of 521 laboratories in the College of American Pathologists Immunohistochemistry (MK) Survey Mod. Pathol. 15 2002 141A
12. B. Wallner, A. Sylvan, K.G. Janunger, B. Bozoky, and R. Stenling Immunohistochemical markers for Barrett's esophagus and associations to esophageal Z-line appearance Scand. J. Gastroenterol. 9 2001 910 915
13. R. Odze Cytokeratin 7/20 immunostaining: Barrett's esophagus or intestinal metaplasia? Lancet 359 2002 1711 1713
14. S.R. DeMeester, K.S. Wickramasinghe, and R.V. Lord Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus Am. J. Gastroenterol. 97 2002 2514 2523
15. I.A. Mohammed, C.J. Streutker, and R.H. Riddell Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia Mod. Pathol. 15 2002 611 616
16. M. Sarbia, A. Donner, C. Franke, and H.E. Gabbert Distinction between intestinal metaplasia in the cardia and in Barrett's esophagus: the role of histology and immunohistochemistry Hum. Pathol. 35 2004 371 376
17. J. Andersen, T.F. Orntoft, and H.S. Poulsen Immunohistochemical demonstration of estrogen receptors (ER) in formalin-fixed, paraffin-embedded human breast cancer tissue by use of a monoclonal antibody to ER J. Histochem. Cytochem. 36 1988 1553 1560
18. M.M. Arnold, S. Srivastava, and J. Fredenburgh Effects of fixation and tissue processing on immunohistochemical demonstration of specific antigens Biotech. Histochem. 71 1996 224 230